Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ioMist
- Development stage
- Unknown
- Lead developer
- ioTech International
- Modality
- Small Molecules
- Administration
- Intranasal
01
Overview
ioMist is an over-the-counter intranasal saline spray product developed by ioTech International for nasal cleansing, congestion relief, and support of sinus and nasal hygiene. It is a proprietary formulation containing molecular iodine stabilized in saline with xylitol, marketed as a drug-free nasal care product rather than a prescription pharmaceutical. Its intended activity appears to be local topical cleansing and antimicrobial support within the nasal cavity, with molecular iodine serving as a broad antiseptic ingredient rather than a targeted receptor-directed therapeutic mechanism.
- Brand names
- ioMist
- Other names
- ioMist nasal spray
Beyond the preview
Go deeper on ioMist.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ioMist.